Topiramate Capsule, Extended Release
FDA Label NDC 70771-1659

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Topiramate (NDC 70771-1659). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1656-3

Topiramate extended-release Capsules 25 mg

Rx only

30 Capsules

25 mg Label (763fe6df 61ab 49ac Bfd7 529c298d8154 01)

NDC 70771-1657-3

Topiramate extended-release Capsules 50 mg

Rx only

30 Capsules

50 mg Label (763fe6df 61ab 49ac Bfd7 529c298d8154 02)

NDC 70771-1658-3

Topiramate extended-release Capsules 100 mg

Rx only

30 Capsules

100 mg Label (763fe6df 61ab 49ac Bfd7 529c298d8154 03)

NDC 70771-1659-3

Topiramate extended-release Capsules 150 mg

Rx only

30 Capsules

150 mg Label (763fe6df 61ab 49ac Bfd7 529c298d8154 04)

NDC 70771-1660-3

Topiramate extended-release Capsules 200 mg

Rx only

30 Capsules

200 mg Label (763fe6df 61ab 49ac Bfd7 529c298d8154 05)

* Please review the disclaimer below.